The impact of the first peak of the COVID-19 pandemic on colorectal cancer services in England and Wales: A national survey.

Abstract

AimThe object of this work was to study how National Health Service hospitals in England and Wales aimed to maintain effective and safe colorectal cancer (CRC) services during the first peak of the COVID‐19 pandemic (April 2020).MethodA national survey was performed among all 148 hospitals providing CRC services. Information was collected about changes in referrals, diagnostic, staging and therapeutic procedures, as well as whether there was access to a ‘cold site’ (a hospital facility free of COVID‐19). Clinicians in each hospital were also asked to give the ‘single most important lesson learned’ about keeping services safe and effective.ResultsFull responses were received from 123 (83%) hospitals, and information about ‘cold sites’ was available for 146 (99%). Eighty hospitals (54%) had access to a ‘cold site’ and this was increased in regions with higher COVID‐19 infection rates (p <0.001). Of the 123 responding hospitals, 105 (85%) indicated that referrals of patients with suspected CRC had dropped by at least 30%, and 69 (56%) indicated that treatment plans were altered in at least 50% of CRC patients. However, ‘cold site’ availability protected the capacity for diagnostic colonoscopy (p = 0.013) and CRC resection (p = 0.010). Many ‘lessons learned’ highlighted the importance of adequate structural service organization, often mentioning ‘cold sites’ and regional coordination as examples, good communication and triage of patients based on clinical urgency.ConclusionAccess to ‘cold sites’, as well as regional coordination, clear communication and strong leadership, were found to be pivotal in maintaining capacity for diagnosis and treatment of CRC during the COVID‐19 surge.